Cargando…

MicroRNA-126 inhibits invasion in bladder cancer via regulation of ADAM9

BACKGROUND: The miRNA deregulation is commonly observed in human malignancies, where they act as tumour suppressors or oncogenes. Despite the association of several miRNAs with bladder cancer, little is known about the miRNAs that contribute to bladder cancer progression from non-muscle invasive (NM...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jia, A Y, Castillo-Martin, M, Bonal, D M, Sánchez-Carbayo, M, Silva, J M, Cordon-Cardo, C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2014
Materias:	Molecular Diagnostics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4056059/ https://www.ncbi.nlm.nih.gov/pubmed/24823697 http://dx.doi.org/10.1038/bjc.2014.245

Ejemplares similares

Identification of DNA hypermethylation of SOX9 in association with bladder cancer progression using CpG microarrays
por: Aleman, A, et al.
Publicado: (2008)

An evaluation of urinary microRNA reveals a high sensitivity for bladder cancer
por: Miah, S, et al.
Publicado: (2012)

microRNA-221 and microRNA-18a identification in stool as potential biomarkers for the non-invasive diagnosis of colorectal carcinoma
por: Yau, T O, et al.
Publicado: (2014)

MicroRNA-126 and epidermal growth factor-like domain 7–an angiogenic couple of importance in metastatic colorectal cancer. Results from the Nordic ACT trial
por: Hansen, T F, et al.
Publicado: (2013)

A urinary microRNA signature can predict the presence of bladder urothelial carcinoma in patients undergoing surveillance
por: Sapre, Nikhil, et al.
Publicado: (2016)

Applications of array technology: identification of molecular targets in bladder cancer
por: Sánchez-Carbayo, M, et al.
Publicado: (2003)

Tumour-suppressive microRNA-144-5p directly targets CCNE1/2 as potential prognostic markers in bladder cancer
por: Matsushita, R, et al.
Publicado: (2015)

Identifying microRNAs regulating B7-H3 in breast cancer: the clinical impact of microRNA-29c
por: Nygren, M K, et al.
Publicado: (2014)

MicroRNA-183 promotes proliferation and invasion in oesophageal squamous cell carcinoma by targeting programmed cell death 4
por: Ren, L-H, et al.
Publicado: (2014)

ADAM10: a new player in breast cancer progression?
por: Mullooly, Maeve, et al.
Publicado: (2015)

Detection of gastric cancer-associated microRNAs on microRNA microarray comparing pre- and post-operative plasma
por: Konishi, H, et al.
Publicado: (2012)

Regulation of ITGA3 by the dual-stranded microRNA-199 family as a potential prognostic marker in bladder cancer
por: Sakaguchi, Takashi, et al.
Publicado: (2017)

Downregulation of miR-126 induces angiogenesis and lymphangiogenesis by activation of VEGF-A in oral cancer
por: Sasahira, T, et al.
Publicado: (2012)

Identification of tumour suppressive microRNA-451a in hypopharyngeal squamous cell carcinoma based on microRNA expression signature
por: Fukumoto, I, et al.
Publicado: (2014)

Identification of serum microRNA profiles in colon cancer
por: Hofsli, E, et al.
Publicado: (2013)

The functional significance of microRNA-145 in prostate cancer
por: Zaman, M S, et al.
Publicado: (2010)

Circulating microRNAs in plasma of patients with gastric cancers
por: Tsujiura, M, et al.
Publicado: (2010)

MicroRNA expression signature of oral squamous cell carcinoma: functional role of microRNA-26a/b in the modulation of novel cancer pathways
por: Fukumoto, I, et al.
Publicado: (2015)

MicroRNA profile: a promising ancillary tool for accurate renal cell tumour diagnosis
por: Silva-Santos, R M, et al.
Publicado: (2013)

Tumour suppressor microRNA-584 directly targets oncogene Rock-1 and decreases invasion ability in human clear cell renal cell carcinoma
por: Ueno, K, et al.
Publicado: (2011)

Tumour-suppressive microRNA-29s inhibit cancer cell migration and invasion by targeting laminin–integrin signalling in head and neck squamous cell carcinoma
por: Kinoshita, T, et al.
Publicado: (2013)

Expression of a disintegrin and metalloprotease (ADAM and ADAMTS) enzymes in human non-small-cell lung carcinomas (NSCLC)
por: Rocks, N, et al.
Publicado: (2006)

Identification of circulating microRNAs as diagnostic biomarkers for use in multiple myeloma
por: Jones, C I, et al.
Publicado: (2012)

ING1b-inducible microRNA203 inhibits cell proliferation
por: Chen, J, et al.
Publicado: (2013)

Circulating microRNAs as prognostic therapy biomarkers in head and neck cancer patients
por: Summerer, I, et al.
Publicado: (2015)

MicroRNA-143 targets DNA methyltransferases 3A in colorectal cancer
por: Ng, E K O, et al.
Publicado: (2009)

Circulating microRNAs in plasma of patients with oesophageal squamous cell carcinoma
por: Komatsu, S, et al.
Publicado: (2011)

MicroRNA-206 expression levels correlate with clinical behaviour of rhabdomyosarcomas
por: Missiaglia, E, et al.
Publicado: (2010)

MicroRNA-126 inhibits proliferation and metastasis in prostate cancer via regulation of ADAM9
por: Hua, Yibo, et al.
Publicado: (2018)

EIF5A2 predicts outcome in localised invasive bladder cancer and promotes bladder cancer cell aggressiveness in vitro and in vivo
por: Wei, J-H, et al.
Publicado: (2014)

The small-nucleolar RNAs commonly used for microRNA normalisation correlate with tumour pathology and prognosis
por: Gee, H E, et al.
Publicado: (2011)

Exosomal microRNA in serum is a novel biomarker of recurrence in human colorectal cancer
por: Matsumura, T, et al.
Publicado: (2015)

Elevated serum CXCL16 is an independent predictor of poor survival in ovarian cancer and may reflect pro-metastatic ADAM protease activity
por: Gooden, M J M, et al.
Publicado: (2014)

Regulation of E3 ubiquitin ligase-1 (WWP1) by microRNA-452 inhibits cancer cell migration and invasion in prostate cancer
por: Goto, Yusuke, et al.
Publicado: (2016)

MicroRNA-125b regulates proliferation and radioresistance of oral squamous cell carcinoma
por: Shiiba, M, et al.
Publicado: (2013)

Overexpression of microRNA-223 regulates the ubiquitin ligase FBXW7 in oesophageal squamous cell carcinoma
por: Kurashige, J, et al.
Publicado: (2012)

MicroRNA-145 inhibits tumour growth and metastasis in colorectal cancer by targeting fascin-1
por: Feng, Y, et al.
Publicado: (2014)

Changes in circulating microRNA levels associated with prostate cancer
por: Bryant, R J, et al.
Publicado: (2012)

microRNA-22, downregulated in hepatocellular carcinoma and correlated with prognosis, suppresses cell proliferation and tumourigenicity
por: Zhang, J, et al.
Publicado: (2010)

MicroRNA expression signature of castration-resistant prostate cancer: the microRNA-221/222 cluster functions as a tumour suppressor and disease progression marker
por: Goto, Yusuke, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_6gb479fjekks6ql6mgs4kf1knp